A decentralized trial handoff sheet keeps coordinators and patients aligned on what happens remotely, what happens at the site, what may happen locally, and who owns each next action.
In this guide
Key points
- Hybrid and decentralized workflows need patient-facing and coordinator-facing handoff views.
- Each remote, local, or site-based step should have an owner, timing expectation, support contact, and missed-step recovery path.
- The handoff sheet should reduce confusion without promising remote convenience beyond what the approved workflow supports.
Decentralized elements add handoffs
Decentralized trial elements can make participation easier, but they also create more handoff points. A patient may interact with a coordinator, telehealth staff, local provider, home health vendor, lab, device-support team, shipping workflow, and the research site.
FDA's final guidance on decentralized elements says trial activities may occur remotely at locations convenient for participants, including telehealth visits, in-home visits, and visits with local health care providers.
Create two versions
The coordinator version should include workflow owners, approved language, timing, escalation rules, technology support, missed-step handling, and documentation expectations.
The patient version should be shorter: what happens next, who may contact you, what may be remote, what may require travel, and where to ask questions.
Avoid overpromising convenience
Remote prescreening does not mean the whole study is remote. A handoff sheet should explain when screening, procedures, labs, baseline visits, or follow-up may require travel or local-provider coordination.
The safest wording is specific: some steps may happen remotely, while other steps may require the research site or another approved location.
Connect the handoff to the queue
The handoff sheet is useful only if the coordinator queue shows the current owner and next action. If the device shipment is late, the local lab order is incomplete, or the patient is waiting for a callback, the workflow should show that blocker.
A weekly review can compare the handoff sheet against actual queue blockers. If the same step keeps failing, the fix may be vendor instructions, patient-facing language, owner assignment, or escalation timing rather than another reminder to coordinators.
TrialsNest can help teams keep those handoffs visible across public interest, coordinator follow-up, study status, and sponsor-facing recruitment visibility while approved study systems remain the source for regulated study records.
Illustrative example
Case-style example
A hybrid study allows remote follow-up but requires in-person screening. Recruitment copy emphasizes convenience, and patients arrive at scheduling expecting no site travel.
Coordinators repeatedly reset expectations after the patient has already submitted interest.
The handoff sheet separates remote prescreen, site screening, local-provider steps, and follow-up options before scheduling begins.
Field note
The handoff sheet is where vague language like hybrid-friendly becomes operational: who calls, what happens remotely, what still requires travel, and what the patient should wait for before taking action.
Common mistakes
Calling the study remote when only prescreening is remote
Patients need to know whether screening, baseline visits, procedures, or follow-up steps still require site travel.
Leaving vendors outside the workflow
If a device, lab, shipping, home health, or telehealth vendor touches the participant experience, the coordinator needs a handoff owner and escalation path.
Before you start
- Map each step by location: Label the activity as remote, in-home, local provider, local lab, research site, or study-team review.
- Assign the owner: Name the coordinator, investigator, vendor, local provider, sponsor contact, or site team responsible for the next action.
- Write the patient version: Give patients a short sequence: what happens next, who may contact them, what may be remote, what may require travel, and where questions should go.
- Which step happens next, and who contacts the patient?
- Which activities are remote, local, in-home, or site-based?
- What should the patient do if the remote, local, or shipping step does not happen on time?
Sources and editorial notes
Published .
Operational workflow guidance only. Decentralized trial design, participant instructions, and study-specific requirements should follow the approved protocol and study-team review.
- Conducting Clinical Trials With Decentralized Elements — FDA
- Informed Consent FAQs — HHS Office for Human Research Protections
This information is educational. Your study team makes medical, eligibility, and enrollment decisions.
See TrialsNest in action
Bring this workflow into one place.
Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.
Coordinator Today
Your inquiries, priorities, and upcoming visits.
- Inquiries assigned
- 14 3 pending review
- Visits today
- 6 4 in person · 2 virtual
- Action priorities
- 4 Needs attention
- Active studies
- 3 Study A · B · C
Priority tasks
- Review screening intakeInquiry 001 · Study ACompleted
- Verify specimen preparationStudy A · Due 10:00 AMCompleted
- Confirm visit windowInquiry 003 · Follow-upPending
Upcoming visits
- In personInquiry 001
Study A · Baseline visit
View visit details → - TelehealthInquiry 003
Study A · Prescreen
Review appointment → - In personInquiry 004
Study B · Week 4
View visit details →
Keep reading
Improve clinical trial lead follow-up speed without losing context
Operational steps research sites can use to contact interested patients faster while preserving study fit, ownership, records needs, and next actions.
Hybrid clinical trials are not remote everything: an operating playbook
A practical playbook for deciding which clinical trial activities can be site-based, local, in-home, telehealth, or digital while preserving oversight and documentation.
Site recruitment workflow for clinical trials
See the site recruitment workflow for clinical trials, from patient intake and records readiness to patient recruitment tracking dashboards, scheduling, and sponsor updates.
Clinical trial recruitment dashboard weekly review template
A weekly dashboard review should help teams decide what changed, which patients or studies need attention, where stale risk is growing, and what actions should happen before the next sponsor or site review.
